Vanderbilt University
p63 Amplification, overexpression occurs early in developing lung cancer
Published in Medical Device Business Week, January 12th, 2004
According to recent research published in the journal Cancer Research, "The fight against lung cancer is greatly compromised by the lack of effective early detection strategies.
"Genomic abnormalities and specifically the amplification of chromosomal region 3q26-3qter in lung cancer represent a major signature of neoplastic transformation. Here, we address the significance of p53 homologue p63 mapping to 3q27 in lung tumorigenesis," wrote P.P. Massion and colleagues, Vanderbilt University, Ingram Comprehensive Cancer Center.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Akers Biosciences, Inc.
Biotech company announces cancellation of shares - Enzo Biochem, Inc.
Gene identification company reports 73.7% gross profit margin - M.D. Anderson Cancer Center
IIp45 antagonizes IGFBP-2 stimulation of glioma cell invasion - M.D. Anderson Cancer Center
PI3-K pathway may be major pathway for trastuzumab-mediated radiosensitization - M.D. Anderson Cancer Center
p27(KIP1) has a novel role in down-regulation of telomerase activity - Manchester Royal Eye Hospital
HSV keratitis can occur in keratoplasty as host reactivation, donor transmission - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
